Dystrophin is a tumor suppressor in human cancers with myogenic programs
Year: 2014
Type: article
Source: Nature Genetics
DOI: 10.1038/ng.2974
Authors: Yuexiang Wang, Adrian Marino-Enriquez, Richard R Bennett, Meijun Zhu, Yiping Shen, Grant Eilers, Jen-Chieh Lee, Joern Henze, Benjamin S Fletcher, Zhizhan Gu, Edward A Fox, Cristina R Antonescu, Christopher D M Fletcher, Xiangqian Guo, Chandrajit P Raut, George D Demetri, Matt van de Rijn, Tamas Ordog, Louis M Kunkel, Jonathan A Fletcher
Institutions: Brigham and Women's Hospital, Harvard University, Boston Children's Hospital, Manton Center for Orphan Disease Research, Shanghai Jiao Tong University, Shanghai Children's Medical Center, Shanghai Children's Hospital, National Taiwan University, National Taiwan University Hospital, Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Stanford Medicine, Stanford University, Dana-Farber/Harvard Cancer Center, Mayo Clinic
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2012208277
